Thursday, October 8, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 30, 2025

TipRanks’ Perfect 10s: Unveiling 3 High-Scoring Stocks for 2026

View original at finance.yahoo.com
TipRanks’ Perfect 10s: Unveiling 3 High-Scoring Stocks for 2026 2026 is just a few days away, and that makes today a good time to start sorting out the best stocks for the new year…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • D-Wave stock has Buy rating with $35 price target

    80% confidence
  • The elegance of Pagaya's two-sided network is starting to resonate across consumer lending ecosystem and with institutional investors, with much more to come

    80% confidence
  • Ouster stock has Overweight (Buy) rating with $33 price target

    80% confidence
  • Current period represents a good entry point for investors with >12-month horizon after recent underperformance

    80% confidence
  • Pagaya delivers more financial opportunity to more people, more often

    80% confidence
  • Ouster will continue to ramp up deployments to self-driving vehicles and autonomous delivery robots via partnerships with Serve Robotics and May Mobility

    80% confidence
  • D-Wave is a full-stack quantum company capable of delivering end-to-end solutions for science and business

    80% confidence
  • Network volume is growing near 20% despite continued prudent underwriting standards

    80% confidence
  • Broad commercial adoption is the next major catalyst for quantum computing industry and D-Wave in particular

    80% confidence
  • D-Wave is a compelling investment due to combination of large addressable market, real-world benefits from optimization across many industries, and expected energy efficiencies

    80% confidence
  • Pagaya sits near a real inflection point with more big lenders joining the platform, expanding monetization, improving loan portfolios, and diversifying lending sources

    80% confidence
  • Ouster is best-positioned fundamentally in the LiDAR industry, generating more revenue and better margins than its peers

    80% confidence
  • Pagaya stock has Buy rating with $39 price target

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com
TipRanks’ Perfect 10s: Unveiling 3 High-Scoring Stocks for 2026 — Source | Via News | ViaNews Market